Related references
Note: Only part of the references are listed.Economic Costs of Diabetes in the U.S. in 2012
DIABETES CARE (2013)
A Metabolomics-driven Elucidation of the Anti-obesity Mechanisms of Xanthohumol
Jay S. Kirkwood et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Xanthohumol lowers body weight and fasting plasma glucose in obese male Zucker fa/fa rats
LeeCole L. Legette et al.
PHYTOCHEMISTRY (2013)
Pharmacokinetics of xanthohumol and metabolites in rats after oral and intravenous administration
LeeCole Legette et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2012)
A state-of-the-art overview of the effect of metabolic conjugation on the biological activity of flavonoids
Karsten Beekmann et al.
FOOD & FUNCTION (2012)
Diabetes and Coronary Heart Disease: A Risk Factor for the Global Epidemic
Maguy Chiha et al.
INTERNATIONAL JOURNAL OF HYPERTENSION (2012)
Flavonoids as Promising Lead Compounds in Type 2 Diabetes Mellitus: Molecules of Interest and Structure-Activity Relationship
E. Nicolle et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Metabolism and Disposition of Isoflavone Conjugated Metabolites in Humans after Ingestion of Kinako
Kaori Hosoda et al.
DRUG METABOLISM AND DISPOSITION (2011)
Equol: Pharmacokinetics and Biological Actions
Kenneth D. R. Setchell et al.
JOURNAL OF NUTRITION (2010)
Triggering of dendritic cell apoptosis by xanthohumol
Nguyen Thi Xuan et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2010)
Xanthohumol and Related Prenylated Flavonoids Inhibit Inflammatory Cytokine Production in LPS-Activated THP-1 Monocytes: Structure-Activity Relationships and In Silico Binding to Myeloid Differentiation Protein-2 (MD-2)
Michael R. Peluso et al.
PLANTA MEDICA (2010)
Xanthohumol from Hop (Humulus lupulus L.) Is an Efficient Inhibitor of Monocyte Chemoattractant Protein-1 and Tumor Necrosis Factor-α Release in LPS-Stimulated RAW 264.7 Mouse Macrophages and U937 Human Monocytes
Elvira Lupinacci et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2009)
Microbial and dietary factors associated with the 8-prenylnaringenin producer phenotype: a dietary intervention trial with fifty healthy post-menopausal Caucasian women
Selin Bolca et al.
BRITISH JOURNAL OF NUTRITION (2007)
Interspecies prediction of human drug clearance based on scaling data from one or two animal species
Huadong Tang et al.
DRUG METABOLISM AND DISPOSITION (2007)
Identification of human hepatic cytochrome P450 enzymes involved in the metabolism of 8-prenylnaringenin and isoxanthohumol from hops (Humulus lupulus L.)
Jian Guo et al.
DRUG METABOLISM AND DISPOSITION (2006)
Xanthohumol, the chalcone from beer hops (Humulus lupulus L.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-Ay mice
H Nozawa
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Activation of proestrogens from hops (Humulus lupulus L.) by intestinal microbiota;: Conversion of isoxanthohumol into 8-prenylnaringenin
S Possemiers et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2005)
Broad spectrum antiinfective potential of xanthohumol from hop (Humulus lupulus L.) in comparison with activities of other hop constituents and xanthohumol metabolites
C Gerhauser
MOLECULAR NUTRITION & FOOD RESEARCH (2005)
Synthesis of phytoestrogenic isoflavonoid disulfates
O Soidinsalo et al.
STEROIDS (2004)
Xanthohumol and related prenylflavonoids from hops and beer: to your good health!
JF Stevens et al.
PHYTOCHEMISTRY (2004)
Oestrogenic activity of the hop phyto-oestrogen, 8-prenylnaringenin
S Milligan et al.
REPRODUCTION (2002)
Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro
CL Miranda et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2000)